QVIDTVM Management LLC
In its 13F for Q1 2025 (holdings as of March 31, 2025, filed May 12, 2025), QVIDTVM Management LLC reported 8 stock positions worth $113.1 million. Its top holding was Solventum (SOLV) at 34.5% of the portfolio, followed by Bio-Rad Laboratories-A (BIO, 27.2%) and Rentokil Initial PLC-SP ADR (RTO, 13.3%). Compared with Q4 2024, it opened 1 new position, sold out of 1, added to 5 and reduced 2. The biggest buy was a new position in Coty Class A (COTY) and the biggest sale Wabtec (WAB, shares −65%).
- Most Recent 13F
- Q2 2026
- Location
- THE WOODLANDS, TX
- CIK
- 0001912226
- Portfolio Value
- $113.1M (Q1 2025)
- SEC Filing
- 0001912226-25-000003 ↗ filed May 12, 2025
Holdings Value
Holdings 8 stocks · $113.1M
| SOLV Solventum Corp. | 34.55% | 513,926 | $39.1M | Reduce -8.6% |
| BIO Bio-Rad Laboratories-A | 27.17% | 126,200 | $30.7M | Add +6.1% |
| RTO Rentokil Initial PLC-SP ADR | 13.29% | 656,676 | $15.0M | Add +1.2% |
| COTY Coty Inc. Class A | 7.76% | 1,605,020 | $8.8M | New |
| XRAY Dentsply Sirona Inc. | 6.13% | 463,866 | $6.9M | Add +1.1% |
| BRC INC-A | 6.10% | 3,301,681 | $6.9M | Add +0.7% |
| ZGN Ermenegildo Zegna NV | 2.75% | 420,129 | $3.1M | Add +10.9% |
| WAB Wabtec Corp. | 2.24% | 14,001 | $2.5M | Reduce -65.3% |
Portfolio Sells Q4 2024 → Q1 2025
Portfolio Buys Q4 2024 → Q1 2025
All Filings
| Quarter | Positions | 13F Reported Value | Top Holdings |
|---|---|---|---|
| Q2 2026 | 14 | $76.6M | BIO, NBIS, AMRZ, ORCL, SOLV |
| Q1 2026 | 14 | $81.4M | BIO, SOLV, AMRZ, NBIS, ORCL |
| Q4 2025 | 13 | $88.4M | BIO, SOLV, AMRZ, XRAY, ZGN |
| Q3 2025 | 8 | $92.9M | SOLV, BIO, COTY, XRAY, BRC INC-A |
| Q2 2025 | 8 | $99.8M | SOLV, BIO, COTY, XRAY, RTO |
| Q1 2025 | 8 | $113.1M | SOLV, BIO, RTO, COTY, XRAY |
| Q4 2024 | 8 | $124.2M | BIO, SOLV, RTO, BRC INC-A, XRAY |
| Q3 2024 | 8 | $142.9M | BIO, SOLV, WAB, RTO, XRAY |
| Q2 2024 | 7 | $125.0M | BIO, RTO, SOLV, WAB, BRC INC-A |
| Q1 2024 | 10 | $124.2M | BIO, RTO, WAB, BRC INC-A, XRAY |